COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19.
Saved in:
| Title: | COVID-19 Vaccination and Remdesivir are Associated With Protection From New or Increased Levels of Donor-Specific Antibodies Among Kidney Transplant Recipients Hospitalized With COVID-19. |
|---|---|
| Authors: | Killian JT Jr; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Houp JA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Burkholder GA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Roman Soto SA; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Killian AC; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Ong SC; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Erdmann NB; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Goepfert PA; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Hauptfeld-Dolejsek V; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Leal SM Jr; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Zumaquero E; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Nellore A; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Agarwal G; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Kew CE; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Orandi BJ; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Locke JE; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Porrett PM; Department of Surgery, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Levitan EB; School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States., Kumar V; Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Lund FE; Department of Microbiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States. |
| Source: | Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Jul 19; Vol. 35, pp. 10626. Date of Electronic Publication: 2022 Jul 19 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 8908516 Publication Model: eCollection Cited Medium: Internet ISSN: 1432-2277 (Electronic) Linking ISSN: 09340874 NLM ISO Abbreviation: Transpl Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
